TERUMO CORPORATION Funds and ETFs Terumo Corporation
Equities
4543
JP3546800008
Medical Equipment, Supplies & Distribution
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,604 JPY | +0.93% |
|
-2.09% | +12.66% |
| Apr. 12 | Penumbra, Inc. : The underdog in healthcare |  |
| Mar. 18 | Frontier Field Co., Ltd. announced that it has received funding from Terumo Corporation | CI |
ETFs positioned on Terumo Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 0 M€ | +0.44% | - | |
| 0.01% | 0 M€ | +0.45% | - | |
| 0.01% | 0 M€ | +2.89% | - |
Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows:
- cardiac surgery devices (53.5%);
- medical products for hospitals (28.6%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.;
- sanguine transfusion equipments (17.9%).
Net sales break down geographically as follows: Japan (32.9%), America (29.5%), Europe (19.6%), China (7.4%) and other (10.6%).
Calendar
2024-05-13
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
2,604
JPY
Average target price
2,976
JPY
Spread / Average Target
+14.30%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +12.66% | 24.62B | |
| -4.91% | 183B | |
| +0.46% | 108B | |
| -3.62% | 67.51B | |
| +3.26% | 50.67B | |
| +9.11% | 44.7B | |
| +2.41% | 40.95B | |
| +6.39% | 26.8B | |
| +3.83% | 26.71B | |
| -13.28% | 21.38B |
- Stock Market
- Equities
- 4543 Stock
- Funds and ETFs Terumo Corporation